⌕
Agilon Health · AGL · NYSE
Tenet 35 · Weak
Compare
$115.20−1.33%At closeTenet 35 · Weak
$115.20−1.55 (−1.33%)
At close: Nov 17, 2026, 4:00 PM ET· NYSE · USD

Agilon Health (AGL) Income Statement

Is this a real, growing, cash-generative business, or a story propped up by accounting?

Sources Company filings FilingsHow we compute thisNot investment advice

8 figures withheld by our checks. Each blank figure names its reason.

Business engineChoppy: revenue fell 2.1% in FY25, net margin −6.6%. Worth your attention in FY25: Share count (+11.0%). Visible in the receipts below.
The lines that matter · FY21–FY25
Revenue ($M)▼2.1%
5,932.6
FY21→FY25CAGR +40.5%/yr
Net income ($M)▼50.4%
−391.3
FY21→FY25CAGR —
Free cash flow ($M)▼67.5%
−119.0
FY21→FY25CAGR —
What the receipts whisper · what a headline number hides
Share count
+11.0%

14.9mn → 16.6mn diluted shares since FY21. Rising share count dilutes EPS. Growth must outrun it.

Capex
$13.2M

steady at 0.2% of revenue (−0.1% YoY).

What the income statement says · FY21–FY25
Where every revenue dollar goes · FY25 ($M)5932.6Revenue−6092.6COGS−160.0Gross profit−238.5SG&A−463.2Op income71.9Tax & other−391.3Net income

-7¢ of every revenue dollar becomes profit. The biggest cost lever is COGS.

Margin trend · direction beats level Gross Operating Net
108530%sector median net margin ~3%FY21FY25

Over this window: gross 4.3% → -2.7%. Net margin -6.6% is below the sector median.

The receipt · income statement · FY21–FY25 USD thousands except per-share & ratios · hover a line for its definition
The annual and quarterly statements are struck on share counts that differ by a factor of 23.4, so per-share figures cannot be compared across the two tables. Each table's per-share figures are on its own share basis.
USD thousands except per-share & ratios
Line itemTTM †FY25FY24FY23FY22FY21YoYCAGR 21→25
Revenue & profitability
Revenue
6,004,180.05,932,576.06,060,530.04,316,363.02,388,220.01,521,494.0▼2.1%+40.5%
Cost of revenue
7,332,679.06,092,597.00.00.02,276,860.01,455,750.0—+43.0%
Gross profit
−1,328,499.0−160,021.0—A—A111,360.065,744.0——
Selling, general & admin
269,970.0238,536.0268,912.0285,760.0207,789.0427,502.0▼11.3%−13.6%
Total operating expenses
−1,174,550.0303,215.06,352,660.04,548,496.0216,738.0437,986.0▼95.2%−8.8%
Operating incomefeeds ROC rank
−153,949.0−463,236.0−292,130.0−232,133.0−105,378.0−372,242.0▼58.6%—
Other income, net
52,826.059,140.043,304.037,671.014,708.0−10,734.0——
Pretax income
−101,123.0−404,096.0−248,826.0−194,462.0−90,670.0−382,976.0▼62.4%—
Income tax
4,975.01,251.01,451.0791.01,640.0886.0▼13.8%+9.0%
Net incomePiotroski ROA ✕feeds Buffett Quality owner earnings
−87,098.0−391,347.0−260,151.0−262,596.0−106,553.0−406,787.0▼50.4%—
Per share
Diluted EPSbuyback-sensitive
−5.19———————
Diluted shares (mn)
17.6916.5616.4416.3616.3314.92▲0.7%+2.6%
Margins
Gross margin0th pct in Healthcare
−22.1%−2.7%—A—A4.7%4.3%——
Operating margin
−2.6%−7.8%−4.8%−5.4%−4.4%−24.5%▼3.0pp+16.7pp
Net margin
−1.5%−6.6%−4.3%−6.1%−4.5%−26.7%▼2.3pp+20.1pp
† TTM = trailing four quarters through 2026-09-30.A Withheld: cost of revenue is not on file, so the gross margin is not measured.
FY19 – FY20 · 2 more years
Unlock the full history →
2 more years of statements and CSV export are on Premium.Premium · $119/yr · 7-day trial · cancel anytimeUnlock with Premium →
Annual report filed 2026-02-25 · view filings on SEC EDGAR ↗ · reported currency USD · as-filed figures may be later restated.
Statements normalized in our fundamentals DB · Not investment advice.

What was Agilon Health's revenue last fiscal year?

Agilon Health reported revenue of $5,932.6M in fiscal 2025, down 2.1% from fiscal 2024.

What was Agilon Health's net income?

Agilon Health reported net income of −$391.3M in fiscal 2025, a net margin of −6.6%.

Annual and quarterly statements as filed, normalized into one comparable shape · Not investment advice.

Install Tenet on your phone

Tenet home pageMethodology© 2026 Tenet Investing Inc.

Data from Intrinio and Financial Modeling Prep.